Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations.

Baldacchino A, Tolomeo S, Balfour DJ, Matthews K.

Psychol Med. 2019 May;49(7):1174-1184. doi: 10.1017/S0033291718003318. Epub 2018 Nov 20.

PMID:
30457069
2.

Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis.

Baldacchino A, Armanyous M, Balfour DJ, Humphris G, Matthews K.

Neurosci Biobehav Rev. 2017 Feb;73:23-38. doi: 10.1016/j.neubiorev.2016.11.008. Epub 2016 Nov 29. Review.

PMID:
27913280
3.

Metabotropic glutamate receptor 5 as a potential target for smoking cessation.

Chiamulera C, Marzo CM, Balfour DJK.

Psychopharmacology (Berl). 2017 May;234(9-10):1357-1370. doi: 10.1007/s00213-016-4487-3. Epub 2016 Nov 16. Review.

PMID:
27847973
4.

The effect of dietary intervention on the metabolic and behavioural impairments generated by short term high fat feeding in the rat.

McNeilly AD, Gao A, Hill AY, Gomersall T, Balfour DJK, Sutherland C, Stewart CA.

Physiol Behav. 2016 Dec 1;167:100-109. doi: 10.1016/j.physbeh.2016.08.035. Epub 2016 Sep 3.

5.

Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status.

Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, McNeilly AD, Balfour DJ, Savinko T, Wong AK, Viollet B, Sakamoto K, Fagerholm SC, Foretz M, Lang CC, Rena G.

Circ Res. 2016 Aug 19;119(5):652-65. doi: 10.1161/CIRCRESAHA.116.308445. Epub 2016 Jul 14.

6.

Preface.

Balfour DJ, Munafò MR.

Curr Top Behav Neurosci. 2015;24:v-vi. No abstract available.

PMID:
26322340
7.

Preface.

Balfour DJ, Munafò MR.

Curr Top Behav Neurosci. 2015;23:v-vi. No abstract available.

PMID:
26322339
8.

The role of mesoaccumbens dopamine in nicotine dependence.

Balfour DJ.

Curr Top Behav Neurosci. 2015;24:55-98. doi: 10.1007/978-3-319-13482-6_3. Review.

PMID:
25638334
9.

High fat feeding is associated with stimulation of the hypothalamic-pituitary-adrenal axis and reduced anxiety in the rat.

McNeilly AD, Stewart CA, Sutherland C, Balfour DJ.

Psychoneuroendocrinology. 2015 Feb;52:272-80. doi: 10.1016/j.psyneuen.2014.12.002. Epub 2014 Dec 9.

PMID:
25544739
10.

Impulsivity and opioid drugs: differential effects of heroin, methadone and prescribed analgesic medication.

Baldacchino A, Balfour DJ, Matthews K.

Psychol Med. 2015 Apr;45(6):1167-79. doi: 10.1017/S0033291714002189. Epub 2014 Aug 29.

PMID:
25171718
11.

Extrasynaptic glycine receptors of rodent dorsal raphe serotonergic neurons: a sensitive target for ethanol.

Maguire EP, Mitchell EA, Greig SJ, Corteen N, Balfour DJ, Swinny JD, Lambert JJ, Belelli D.

Neuropsychopharmacology. 2014 Apr;39(5):1232-44. doi: 10.1038/npp.2013.326. Epub 2013 Nov 22.

12.

A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin.

McNeilly AD, Williamson R, Balfour DJ, Stewart CA, Sutherland C.

Diabetologia. 2012 Nov;55(11):3061-70. doi: 10.1007/s00125-012-2686-y. Epub 2012 Aug 18. Erratum in: Diabetologia. 2013 Jan;56(1):230.

PMID:
22898768
13.

Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

Baldacchino A, Balfour DJ, Passetti F, Humphris G, Matthews K.

Neurosci Biobehav Rev. 2012 Oct;36(9):2056-68. doi: 10.1016/j.neubiorev.2012.06.006. Epub 2012 Jul 6. Review.

PMID:
22771335
14.

Nicotine modifies in vivo and in vitro rat hippocampal amyloid precursor protein processing in young but not old rats.

Scerri C, Stewart CA, Balfour DJ, Breen KC.

Neurosci Lett. 2012 Apr 11;514(1):22-6. doi: 10.1016/j.neulet.2012.02.042. Epub 2012 Feb 22.

PMID:
22381398
15.

Historical and current perspective on tobacco use and nicotine addiction.

Dani JA, Balfour DJ.

Trends Neurosci. 2011 Jul;34(7):383-92. doi: 10.1016/j.tins.2011.05.001. Epub 2011 Jun 21. Review.

16.

The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain.

Tronci V, Balfour DJ.

Behav Brain Res. 2011 Jun 1;219(2):354-7. doi: 10.1016/j.bbr.2010.12.024. Epub 2011 Jan 7.

PMID:
21216262
17.

High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task.

McNeilly AD, Williamson R, Sutherland C, Balfour DJ, Stewart CA.

Behav Brain Res. 2011 Feb 2;217(1):134-41. doi: 10.1016/j.bbr.2010.10.017. Epub 2010 Oct 23.

PMID:
20974195
18.

The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine.

Tronci V, Vronskaya S, Montgomery N, Mura D, Balfour DJ.

Psychopharmacology (Berl). 2010 Jul;211(1):33-42. doi: 10.1007/s00213-010-1868-x. Epub 2010 Apr 27.

19.

Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol: a selective role for delta-GABA(A) receptors.

Herd MB, Foister N, Chandra D, Peden DR, Homanics GE, Brown VJ, Balfour DJ, Lambert JJ, Belelli D.

Eur J Neurosci. 2009 Mar;29(6):1177-87. doi: 10.1111/j.1460-9568.2009.06680.x.

20.

The neuronal pathways mediating the behavioral and addictive properties of nicotine.

Balfour DJ.

Handb Exp Pharmacol. 2009;(192):209-33. doi: 10.1007/978-3-540-69248-5_8. Review.

PMID:
19184651
21.

Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.

Paterson NE, Balfour DJ, Markou A.

Nicotine Tob Res. 2008 Jun;10(6):995-1008. doi: 10.1080/14622200802097571.

PMID:
18584463
22.

Influence of 5,7-dihydroxytryptamine lesions of the rat fornix-fimbria and cingulum bundles on spontaneous activity in an aversive maze.

Robertson DA, Beattie JE, Reid IC, Balfour DJ.

J Psychopharmacol. 2008 May;22(3):285-9. doi: 10.1177/0269881107083841.

PMID:
18208913
23.

The effect of stress on the expression of the amyloid precursor protein in rat brain.

Sayer R, Robertson D, Balfour DJ, Breen KC, Stewart CA.

Neurosci Lett. 2008 Feb 6;431(3):197-200. doi: 10.1016/j.neulet.2007.11.032. Epub 2007 Dec 3.

24.
25.

Guidelines on nicotine dose selection for in vivo research.

Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, Lukas RJ, Markou A, Marks MJ, McCallum SE, Parameswaran N, Perkins KA, Picciotto MR, Quik M, Rose JE, Rothenfluh A, Schafer WR, Stolerman IP, Tyndale RF, Wehner JM, Zirger JM.

Psychopharmacology (Berl). 2007 Feb;190(3):269-319. Epub 2006 Aug 9. Review.

PMID:
16896961
26.

Neuropharmacology and potential efficacy of new treatments for tobacco dependence.

Fagerström K, Balfour DJ.

Expert Opin Investig Drugs. 2006 Feb;15(2):107-16. Review.

PMID:
16433591
27.

Behavioural and neurochemical responses evoked by repeated exposure to an elevated open platform.

Storey JD, Robertson DA, Beattie JE, Reid IC, Mitchell SN, Balfour DJ.

Behav Brain Res. 2006 Jan 30;166(2):220-9. Epub 2005 Sep 15.

PMID:
16150498
28.

The effects of chronic nicotine on spatial learning and bromodeoxyuridine incorporation into the dentate gyrus of the rat.

Scerri C, Stewart CA, Breen KC, Balfour DJ.

Psychopharmacology (Berl). 2006 Mar;184(3-4):540-6. Epub 2005 Jul 16.

PMID:
16025316
29.

Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress.

Robertson DA, Beattie JE, Reid IC, Balfour DJ.

Eur J Neurosci. 2005 Mar;21(6):1511-20.

PMID:
15845079
30.

The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected].

Balfour DJ.

Nicotine Tob Res. 2004 Dec;6(6):899-912. Review. Erratum in: Nicotine Tob Res. 2005 Apr;7(2):307.

PMID:
15801566
31.

Nicotine: from molecular mechanisms to behaviour.

Wonnacott S, Sidhpura N, Balfour DJ.

Curr Opin Pharmacol. 2005 Feb;5(1):53-9. Review.

PMID:
15661626
32.

Enhanced evoked responses after early adversity and repeated platform exposure: the neurobiology of vulnerability?

Stewart CA, Petrie RX, Balfour DJ, Matthews K, Reid IC.

Biol Psychiatry. 2004 Apr 15;55(8):868-70.

PMID:
15050869
33.

Neuroplasticity within the mesoaccumbens dopamine system and its role in tobacco dependence.

Balfour DJ.

Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):413-21. Review.

PMID:
12769613
34.

Declaration of policy regarding conflict of interest.

Swan GE, Balfour DJ.

Nicotine Tob Res. 2002 Feb;4(1):1-2. No abstract available.

PMID:
11906677
35.

Conflict of interest and the credibility of nicotine and tobacco research.

Swan GE, Balfour DJ.

Addiction. 2002 Jan;97(1):100-2. No abstract available.

PMID:
11898765
36.

The neurobiology of tobacco dependence: a commentary.

Balfour DJ.

Respiration. 2002;69(1):7-11. Review.

PMID:
11844955
37.

Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain.

Iyaniwura TT, Wright AE, Balfour DJ.

Psychopharmacology (Berl). 2001 Oct;158(1):73-9.

PMID:
11685386
38.

The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion.

Balfour DJ.

Int J Clin Pract. 2001 Jan-Feb;55(1):53-7. Review.

PMID:
11219320
39.

Nicotine & Tobacco Research begins its second year of operation.

Swan GE, Balfour DJ.

Nicotine Tob Res. 2000 Feb;2(1):5-6. No abstract available.

PMID:
11072436
40.

Nicotine & Tobacco Research: a forum for science-based results.

Swan GE, Pomerleau OF, Balfour DJ.

Nicotine Tob Res. 1999 Mar;1(1):5-7. No abstract available.

PMID:
11072384
41.

The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence.

Balfour DJ, Wright AE, Benwell ME, Birrell CE.

Behav Brain Res. 2000 Aug;113(1-2):73-83. Review.

PMID:
10942034
42.

The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?

Balfour DJ, Ridley DL.

Pharmacol Biochem Behav. 2000 May;66(1):79-85. Review.

PMID:
10837846
43.

International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.

Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, Wonnacott S.

Pharmacol Rev. 1999 Jun;51(2):397-401. Review. No abstract available.

PMID:
10353988
45.
46.

Sensitization of the mesoaccumbens dopamine response to nicotine.

Balfour DJ, Benwell ME, Birrell CE, Kelly RJ, Al-Aloul M.

Pharmacol Biochem Behav. 1998 Apr;59(4):1021-30. Review.

PMID:
9586863
47.

Society for Research on Nicotine and Tobacco.

Heishman SJ, Balfour DJ, Benowitz NL, Hatsukami DK, Lindstrom JM, Ockene JK.

Addiction. 1997 May;92(5):615-33.

PMID:
9219386
48.

Regional variation in the effects of nicotine on catecholamine overflow in rat brain.

Benwell ME, Balfour DJ.

Eur J Pharmacol. 1997 Apr 23;325(1):13-20.

PMID:
9151933
49.

Effects of acute D-CPPene on mesoaccumbens dopamine responses to nicotine in the rat.

Balfour DJ, Birrell CE, Moran RJ, Benwell ME.

Eur J Pharmacol. 1996 Dec 5;316(2-3):153-6.

PMID:
8982681
50.

Neurochemical and behavioural interactions between ibogaine and nicotine in the rat.

Benwell ME, Holtom PE, Moran RJ, Balfour DJ.

Br J Pharmacol. 1996 Feb;117(4):743-9.

Supplemental Content

Loading ...
Support Center